Related Experiment Video
Updated: Nov 16, 2025

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
[New drugs and PDTA. Financing methodology for care pathways and overcoming of silos.]
Nello Martini1, Carlo Piccinni1
1Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).
Abstract:
The Research and Health Foundation led a preliminary analysis to understand how drugs are cited and what their weight is within the current diagnostic-therapeutic care pathways (PDTA) referring to chronic diseases. The results highlight the need to provide for the specification of which drugs to use and the related methods of use. The issue is also important due to the connection between specific decisions of the Italian Medicines Agency concerning the access and reimbursement of the drug and their use.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Drug Therapy
Antianxiety Medications
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Clinical Trials: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

